Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VU661013 |
Trade Name | |
Synonyms | |
Drug Descriptions |
VU661013 is a selective inhibitor of MCL1, which prevents Mcl1 from interacting with Bim, thereby potentially inducing apoptosis and inhibiting cell proliferation (PMID: 30185627, PMID: 31595181). |
DrugClasses | MCL1 Inhibitor 18 |
CAS Registry Number | 2131184-57-9 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Navitoclax + VU661013 | Navitoclax VU661013 | 0 | 0 |
Venetoclax + VU661013 | VU661013 Venetoclax | 0 | 0 |
VU661013 | VU661013 | 0 | 0 |